Clinical Trial Update: Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma [Phase 2, Phase 3]

View source ↗

Summary

This report summarizes Phase 2 and Phase 3 results assessing the efficacy and safety of single doses of indacaterol delivered via a single-dose dry powder inhal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED